Literature DB >> 32241068

Influence of chronic kidney disease and haemodialysis on stroke outcome.

Shrikant D Pande1, Julie Morris2.   

Abstract

INTRODUCTION: Stroke patients with underlying chronic kidney disease (CKD) and those on haemodialysis have complex rehabilitation needs, and their survival and functional outcomes are limited. This study aimed to review post-stroke survival and functional outcomes following rehabilitation in patients with CKD and those on haemodialysis.
METHODS: We conducted a retrospective analysis of consecutive stroke patients with underlying CKD (Stages G3b, G4 and G5; n = 30) and those on dialysis at the time of stroke (n = 7), who underwent in-patient rehabilitation between June 2008 and May 2017. The mean duration of follow-up was 56 months. Demographic details, associated comorbidities and laboratory parameters were reviewed. Baseline and follow-up scores of the National Institute of Health Stroke Scale (NIHSS) and Functional Independence Measure (FIM), and dates of death of the patients were analysed.
RESULTS: Of the 37 consecutive stroke patients (mean age 64.7 years), 34 had ischaemic stroke and three had haemorrhagic transformation. Significant improvements in NIHSS and FIM scores were observed from the time of admission to after discharge. Older age, longer duration of hospital stay, lower estimated glomerular filtration rate and low haemoglobin levels were all significantly related to mortality.
CONCLUSION: Despite significant functional and neurological improvements following rehabilitation, stroke patients with underlying CKD had higher average duration of hospital stay, more recurrent hospitalisations and poorer survival outcomes than those without underlying CKD. This could be attributed to the complications associated with CKD rather than stroke. Multidisciplinary community rehabilitation may be an alternative to reduce recurrent hospitalisations and morbidity in this group of patients. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  FIM; NIHSS; chronic kidney disease; haemodialysis; stroke

Mesh:

Year:  2020        PMID: 32241068      PMCID: PMC8804410          DOI: 10.11622/smedj.2020044

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  36 in total

1.  Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study.

Authors:  Albert Power; Kakit Chan; Seema K Singh; David Taube; Neill Duncan
Journal:  Am J Kidney Dis       Date:  2011-09-23       Impact factor: 8.860

2.  Strokes in patients on haemodialysis: incidence, onset time and associated factors.

Authors:  Lara Belmar; Angel L M de Francisco; Laura Bueno; Celestino Piñera; Elena Monfá; María Kislikova; Miguel Seras; Emilio Rodrigo; Manuel Arias
Journal:  Nefrologia       Date:  2014-05-21       Impact factor: 2.033

3.  The functional independence measure: a new tool for rehabilitation.

Authors:  R A Keith; C V Granger; B B Hamilton; F S Sherwin
Journal:  Adv Clin Rehabil       Date:  1987

4.  Classification and natural history of clinically identifiable subtypes of cerebral infarction.

Authors:  J Bamford; P Sandercock; M Dennis; J Burn; C Warlow
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

5.  Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.

Authors:  Masaki Naganuma; Masatoshi Koga; Yoshiaki Shiokawa; Jyoji Nakagawara; Eisuke Furui; Kazumi Kimura; Hiroshi Yamagami; Yasushi Okada; Yasuhiro Hasegawa; Kazuomi Kario; Satoshi Okuda; Kazutoshi Nishiyama; Kazuo Minematsu; Kazunori Toyoda
Journal:  Cerebrovasc Dis       Date:  2010-11-17       Impact factor: 2.762

6.  Predictors of stroke in patients receiving chronic hemodialysis.

Authors:  K Iseki; K Fukiyama
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

7.  Proteinuria and stroke: a meta-analysis of cohort studies.

Authors:  Toshiharu Ninomiya; Vlado Perkovic; Christine Verdon; Federica Barzi; Alan Cass; Martin Gallagher; Meg Jardine; Craig Anderson; John Chalmers; Jonathan C Craig; Rachel Huxley
Journal:  Am J Kidney Dis       Date:  2008-12-13       Impact factor: 8.860

8.  Evidence for high risk of cerebral hemorrhage in chronic dialysis patients.

Authors:  K Iseki; K Kinjo; Y Kimura; A Osawa; K Fukiyama
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

9.  Association between kidney function, rehabilitation outcome, and survival in older patients discharged from inpatient rehabilitation.

Authors:  Edward M Doyle; Joanne M Sloan; James A Goodbrand; Marion E T McMurdo; Peter T Donnan; Mark M McGilchrist; Helen Frost; Miles D Witham
Journal:  Am J Kidney Dis       Date:  2015-06-02       Impact factor: 8.860

Review 10.  Low glomerular filtration rate and risk of stroke: meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Kuo-Hsuan Chang; Hung-Wei Liao; Shen-Chih Chang; Bruce Ovbiagele
Journal:  BMJ       Date:  2010-09-30
View more
  4 in total

1.  Authors' reply: Comment on: Influence of chronic kidney disease and haemodialysis on stroke outcome.

Authors:  Shrikant Pande; Debajyoti Roy
Journal:  Singapore Med J       Date:  2021-11       Impact factor: 1.858

2.  Comment on: Influence of chronic kidney disease and haemodialysis on stroke outcome.

Authors:  Otto J Hernandez Fustes; Carlos Arteaga Rodriguez
Journal:  Singapore Med J       Date:  2021-11       Impact factor: 1.858

3.  Acute kidney injury without need for dialysis, incidence, its impact on long-term stroke survival and progression to chronic kidney disease.

Authors:  Shrikant D Pande; Debajyoti Roy; Aye Aye Khine; May M Win; Lorecar Lolong; Ni Thu Shan; Pei Ting Tan; Tian Ming Tu
Journal:  BMJ Open       Date:  2022-05-25       Impact factor: 3.006

4.  Inflammation promotes erythropoietin induced vascular calcification by activating p38 pathway.

Authors:  Xunjia Li; Chengxuan Liu; Ying Li; Weijian Xiong; Deyu Zuo
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.